- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 4, 2025 | 23.62M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $132.38M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $135.65M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $7.25M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $7.96M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $8.24M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $9.16M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $148.71M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $152.85M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $158.74M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $163.23M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 23.37M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $232K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.3M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $70.17M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $74.27M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.21 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.21 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $3.48M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $897K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$4.56M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$5.06M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $483K |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $6.18M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $6.66M |